All Blogs / Industries / Medical / Pharmaceutical / New

Weekly Roundup 3.23.18

At least here in the mid-Atlantic region, the ground hog appears to have got it wrong, with a week that had quite moderate temperatures. In the herb garden, the chives have popped up, always a harbinger of Spring. I tried … Continue reading ?

Drug Channels News Roundup, February 2018: Walgreens Boots Alliance + AmerisourceBergen, Copay Coupons, and Amazon

Winter—or at least February—is almost over! Bid farewell to the shortest month of the year with this curated selection of noteworthy news. In this issue: A few thoughts on a Walgreens Boots Alliance-AmerisourceBergen deal Watch a fun...Show More Summary

The Top 15 U.S. Pharmacies of 2017: Market Shares and Key Developments For The Biggest Companies

Next week, Drug Channels Institute will release our 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the ninth edition of our popular examination of the U.S. pharmacy distribution and reimbursement system. The...Show More Summary

Join Me at Asembia’s Specialty Pharmacy Summit 2018

Asembia’s Specialty Pharmacy Summit 2018April 29 to May 2, 2018 | Las Please join me at Asembia's Specialty Pharmacy Summit 2018, which will take place from April 29 to May 2, 2018 in Las Vegas.This is a must-attend event for anyone connected to specialty pharmacy. Show More Summary

Weekly Roundup 2.16.18

This week we had 70 degree temperatures and predictions of snow. It seems we are living in roller coaster times – at least for this month. For all the lovers out there, hope the Valentine’s Day was second to none. … Continue reading...

Exclusive Express Scripts Data: Most People Have Very Low Out-Of-Pocket Prescription Costs

In New Express Scripts Data: The Drug Spending Slowdown Is Real, I analyzed the latest drug trend report from pharmacy benefit manager (PBM) Express Scripts. To complement our earlier analysis, Express Scripts was kind enough to provide...Show More Summary

PLOS Pathogens Microbiome Research: A Call for Papers

PLOS Pathogens invites submission of your research on the microbiome (of animals, plants, and humans) and its interactions with infectious disease or the immune system. Microbiota, a community of microorganisms including bacteria, viruses, and fungi,

Journée Scientific Niger

PLOS Medicine Specialty Consulting Editor Lorenz von Seidlein presents some highlights from the first Epicentre scientific day in Niger Epicentre, the research arm of Médecins Sans Frontières, organised its first scientific day in Niger on

FDA’s Strategic Policy Roadmap – Part 2 Addressing Addiction

With deaths rising each year, there is no question of the urgency that something needs to be done to address the opioid misuse epidemic in the United States. And in addition to mortality there are the lives touched by these … Continue reading ?

New Express Scripts Data: The Drug Spending Slowdown Is Real

Last week, Express Scripts released its 2017 Drug Trend Report. (Free download.)  Consider it an early Valentine's Day present for pharma wonks like your friendly neighborhood blogger. The latest data confirm the slowdown in drug spending. Show More Summary

Formulary, CoPay and Access Summit

Formulary, CoPay and Access Summit April 11-12, 2018 | San Francisco, to San Francisco in April for CBI’s Formulary, CoPay and Access Summit, which focuses on overcoming patient affordability barriers in an evolving managed care landscape. Show More Summary

Weekly Roundup 2.9.18

February. When the inconvenient bursts of weird precipitation, the cold and the dark starts really getting on your nerves. They made it the shortest month for a reason. Facing the prospect of yet another government shutdown, it appeared that at … Continue reading ?

FDA’s 2018 Strategic Policy Roadmap, Part 1

In January, FDA’s Commissioner announced the release of “Health Innovation, Safer Families: FDA’s 2018 Strategic Policy Roadmap” that provides a detailed overview of priorities for the agency within a relatively short timeframe. FDA and the various centers that make up … Continue reading ?

Specialty Distributors’ Customer Mix Changes As Physician Buy-and-Bill Fades

In A Lesson from McKesson: How Specialty Pharmacy Growth Is Hurting Wholesalers, I explained the challenges to wholesalers' profits from the growth of patient-administered specialty pharmacy drugs. Today, I provide a complementary look...Show More Summary

Farewell Pharma Friends! Beware of the PharmaGovernment Complex!

It's my 71st birthday and I decided it's a good time for me to move on to a new role. Unbelievable, right? John "PharmaGuy" Mack is seventy-one years old!Also unbelievable is that I am shuttering my pharmaceutical online publishing business...Show More Summary

A Lesson from McKesson: How Specialty Pharmacy Growth Is Hurting Wholesalers

Last week, McKesson released its quarterly earnings for the fourth calendar quarter of 2017. See the links below. The profit outlook for its distribution business was lower than Wall Street’s expectations, due partly to what management...Show More Summary

Partnering with IDNs BioPharma Strategy Summit

Partnering with IDNs BioPharma Strategy SummitMarch 27-28, 2018 | Scottsdale, health systems continue to grow and merge to form larger Integrated Delivery Networks (IDNs), manufacturers are tasked with learning how to best contract with, and sell to, these evolving systems to ensure product success. Show More Summary

Weekly Roundup 2.2.18

Groundhog Day is happening today to bring us the valuable insight related to the length of winter and the beginning of Spring. Exciting, but not as thrilling in my mind as the re-establishment of Daylight Saving Time when the hours … Continue reading ?

Meet The Power Buyers Driving Generic Drug Deflation

Wholesalers and retailers have deepened their relationships via generic purchasing consortia—and generic drug makers are feeling the pain. Example: Novartis’ Sandoz business unit reported that its fourth-quarter 2017 sales dropped by...Show More Summary

Drug Channels News Roundup, January 2018: PBM Exclusions, Hospital Finances, 340B Updates, and Amazon

Here at our worldwide headquarters in Philadelphia, Eagles super bowl fever has landed. Before trying to climb a Crisco-covered light pole, please enjoy this month’s playbook of articles, intercepted for you from the Drug Channels gridiron. An...Show More Summary

Copyright © 2015 Regator, LLC